Bicara Therapeutics

BCAXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.844 B

$28.06 +2.00%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$137.9M

Loss-making

Shares outstanding

65,467,187

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#117COMPASS PathwaysCMPS$1.87B
#118NanobiotixNBTX$1.85B
#119Bicara TherapeuticsBCAX$1.84B
#120Damora TherapeuticsDMRA$1.84B
#121Generate BiomedicinesGENB$1.84B

Where these numbers come from

Share counts and financials for Bicara Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.